An AI Firm Wants to Predict Costly Pharma Flops

(Bloomberg) -- Before Biogen Inc.’s experimental Alzheimer’s disease drug failed in a trial last month, analysts surveyed by Bloomberg estimated annual sales of about $3.7 billion by 2023. A German...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.